Cancer

The latest cancer news from UNC Health Care and the UNC School of Medicine.

UNC Lineberger teams with Duke, WUSTL to speed drug development

UNC Lineberger teams with Duke, WUSTL to speed drug development

The new collaborative effort capitalizes on the scientific and clinical strengths of the comprehensive cancer centers at each of the three institutions, working within the National Cancer Institute’s Experimental Therapeutics Clinical Trials Network (ETCTN).

UNC Lineberger teams with Duke, WUSTL to speed drug development - Read More…

A Path Divergent

A Path Divergent

Five Questions for Robert Sandler, a world-renowned gastroenterologist who has challenged a major theory about the cause of diverticulosis.

A Path Divergent - Read More…

UNC researchers discover “master regulator” role for little-known protein in cancer cells

UNC researchers discover “master regulator” role for little-known protein in cancer cells

Previously thought to only play a role in male fertility, the protein DAZAP1 has now been shown to be a major player in how genes are expressed; in cell culture experiments it stifled the progression of several types of cancer cells.

UNC researchers discover “master regulator” role for little-known protein in cancer cells - Read More…

Pope Foundation gives $1.3 million to UNC Lineberger to fight cancer

The John William Pope Foundation has made a $1.3 million gift to UNC Lineberger Comprehensive Cancer Center to fund cancer research and treatment.

Pope Foundation gives $1.3 million to UNC Lineberger to fight cancer - Read More…

Solving Cancer’s Secrets

Solving Cancer’s Secrets

Five questions for Chuck Perou, PhD, a UNC geneticist on the hunt for better treatments for the most deadly form of breast cancer

Solving Cancer’s Secrets - Read More…

A Grand Opening

A Grand Opening

With the dedication of Marsico Hall, UNC ushered in a new era of medical research, collaboration, and promise for the people of North Carolina and beyond.

A Grand Opening - Read More…

UNC researchers show cancer chemotherapy accelerates ‘molecular aging’

UNC researchers show cancer chemotherapy accelerates ‘molecular aging’

Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.

UNC researchers show cancer chemotherapy accelerates ‘molecular aging’ - Read More…

UNC scientists reveal how cells destroy RNA, a key to understanding disease

The finding, from the lab of William Marzluff, PhD, provides insight into how genetic diseases, such as various cancers, develop in the body.

UNC scientists reveal how cells destroy RNA, a key to understanding disease - Read More…

Genetic, non-invasive test could improve colon cancer screening

Genetic, non-invasive test could improve colon cancer screening

The large-scale, cross-sectional study was published in The New England Journal of Medicine. Dr. David Ransohoff of UNC is one of the study's co-authors.

Genetic, non-invasive test could improve colon cancer screening - Read More…

UNC researchers create new tool to unravel mysteries of metastasis

The lab of Klaus Hahn, PhD, developed a new technique to help scientists map the interactions between the proteins at the heart of many diseases.

UNC researchers create new tool to unravel mysteries of metastasis - Read More…

Inside Our Cellular Invaders

Inside Our Cellular Invaders

When we fight an infection -- any invader -- our bodies conjure inflammatory responses, immune responses. But inside some individual cells, a similar reaction happens. Beth Knight, PhD, found out what transpires inside such cells involved in a kind of brain cancer called medulloblastoma and what role a particularly important protein plays in cancer development. This is the second profile in a continuing series of features on UNC School of Medicine graduate students.

Inside Our Cellular Invaders - Read More…

UNC study reveals potential route to bladder cancer diagnostics, treatments

UNC study reveals potential route to bladder cancer diagnostics, treatments

Researchers at the UNC Lineberger Comprehensive Cancer Center found that bladder cancer subtypes are genetically similar to breast cancer subtypes.

UNC study reveals potential route to bladder cancer diagnostics, treatments - Read More…

Kay Yow Cancer Fund awards $1 million research grant to UNC Lineberger

Kay Yow Cancer Fund awards $1 million research grant to UNC Lineberger

The Kay Yow Cancer Fund®, in partnership with The V Foundation for Cancer Research, has awarded a $1 million women’s cancer research grant to UNC Lineberger to evaluate the impact of physical activity among breast cancer survivors.

Kay Yow Cancer Fund awards $1 million research grant to UNC Lineberger - Read More…

Improved ultrasound imaging provides alternate way to visualize tumors

Improved ultrasound imaging provides alternate way to visualize tumors

The new technique, developed by UNC researchers, would be cheaper and could allow doctors to visualize tumors without the use of radiation.

Improved ultrasound imaging provides alternate way to visualize tumors - Read More…

Early tumor response from stereotactic radiosurgery predicts outcome

Early tumor response from stereotactic radiosurgery predicts outcome

This research could reduce the need to continually monitor patients who respond well to stereotactic radiosurgery.

Early tumor response from stereotactic radiosurgery predicts outcome - Read More…

A powerful technique to further understanding of RNA

A powerful technique to further understanding of RNA

Qi Zhang sees himself as a warrior. In his lab at the University of North Carolina at Chapel Hill, he wages war on genetic diseases such as cancer and heart disease on a battlefield measured with single atoms.

A powerful technique to further understanding of RNA - Read More…

Top of the Line

Top of the Line

The next chapter in the story of UNC Lineberger Comprehensive Cancer Center begins with a new director, Ned Sharpless, an oncologist with a story to tell.

Top of the Line - Read More…

Out-of-pocket costs play major role in treatment adherence for cancer patients

Out-of-pocket costs play major role in treatment adherence for cancer patients

The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient’s share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina.

Out-of-pocket costs play major role in treatment adherence for cancer patients - Read More…

Share This: